Paper708574
Measurement of oestradiol receptors by five institutions on common tissue samples.
King RJ and 5 others. Br J Cancer, 1978. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Measurement of oestradiol receptors by five institutions on common tissue samples. Papers, record 708574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/708574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estradiol | Major topic |
| Receptors, Estrogen | Major topic |
| Female | |
| Humans | |
| Methods | |
| Sulfhydryl Compounds | |
| Tissue Preservation | |
| United Kingdom |
Source PubMed
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 200253 | Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. | Br J Cancer | 1977 | https://conductscience.org/library/papers/200253 | PubMed |
| 2 | 708575 | Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. | Br J Cancer | 1978 | https://conductscience.org/library/papers/708575 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9502414 | Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9502414 | PubMed |
| 7348574 | Oestrogen receptor concentration in primary breast cancer and axillary node metastases. | Breast Cancer Res Treat | 1981 | https://conductscience.org/library/papers/7348574 | PubMed |
| 6849801 | The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6849801 | PubMed |
| 6367854 | Quality control of estrogen receptor assays in The Netherlands. | Breast Cancer Res Treat | 1983 | https://conductscience.org/library/papers/6367854 | PubMed |
| 3447645 | Oestrogen receptor activity in breast cancer detected at a prevalence screening examination. | Breast Cancer Res Treat | 1987 | https://conductscience.org/library/papers/3447645 | PubMed |
| 2900647 | Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation. | Br J Cancer | 1988 | https://conductscience.org/library/papers/2900647 | PubMed |
| 708575 | Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. | Br J Cancer | 1978 | https://conductscience.org/library/papers/708575 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/708574
GET https://conductscience.org/api/papers/v1/708574/authors